UPDATE 1-Baxter revenue falls short of estimates, hit by dollar

Feb 2 (Reuters) - Hospital products and drug maker Baxter International Inc's quarterly revenue fell 7 percent and missed analyst estimates, hurt by a strong dollar and increased generic competition for its chemotherapy treatment in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.